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Introduction
The last 20 years have seen major changes in the prac- tration has rapidly grown as an important treatment for
tice of critical care medicine. Initially sustained by emerg- acute patients. From the original description of Peter
ing mechanical ventilation technology and the part-time Kramer in 1977 as a possible alternative to established
dedication of interested anesthesiologists, it has gone on techniques, today hemofiltration is a first choice tech-
to become an established feature of all tertiary institu- nique for several clinical conditions, particularly multiple
tions, with dedicated and trained specialists, an expand- organ failure. The success of this technique, however,
ing specific knowledge base, and ongoing research unique relies on a strong collaboration between the nephrologist
to its needs. and the intensive care specialist.
Critical care medicine is now a well-established medi- There are important clinical reasons for collaborative
cal specialty with specific therapies, publications, practi- care. Patients with renal failure are significantly more
cal and cognitive skills, and procedures. The develop- complex than 30 years ago. They almost always are el-
ment of intensive care units in particular has had major derly, have significant comorbidity, and have dysfunction
implications for the kind of surgery that can be performed of multiple organs. Renal failure cannot be viewed as a
routinely (such as coronary artery by-pass surgery) and simple problem that will get better over time once the
for the type of patients (older and with significant chronic initial insult is gone and sufficient renal replacement
diseases) who can be successfully treated. The evolution therapy has been provided. Insights into such renal re-
of critical care medicine has also had significant implica- placement therapy now reveal that the therapy itself may
tions for clinical nephrologists. One major development make a great deal of difference in the course of the
has to do with the nature, epidemiology, and manage- disease.
ment of severe acute renal failure (ARF). The use of continuous renal replacement therapy
Severe ARF is now profoundly different in its epidemi-
(CRRT) has partly redefined the indications for initiating
ology and associations from the disease seen by nephrolo-
dialytic therapy in the intensive care unit. It has ex-gists 30 years ago. It is now seen predominantly in inten-
panded the possible role of blood purification in thesive care units, is usually associated with the dysfunction
management of critically ill patients, and it has widenedof other organs, and is often accompanied by sepsis. It
the scope of interaction between the expertise of theis typically multifactorial, and has a very high mortality
nephrologist, the needs of the intensive care specialist,rate.
and their common goals for patient recovery. CriticallyThe management of this type of ARF demands the
ill patients keep dying at unacceptably high rates. Surelyapplication of complex knowledge and skills. Such knowl-
the answer to such a high mortality rate must be thatedge and skills can come either from only a multidiscipli-
physicians need to combine knowledge and expertise, benary approach in which nephrologist and intensivist work
modest and collegial, and be constructive, nonconflictual,side by side to achieve optimal care for a given patient,
and interdisciplinary in their approach to patient care.or only from specialists originally from either field who
In this issue of Kidney International, we collected thehave gone on to formally acquire training and expertise
contributions presented as review and original articlesin both specialties.
at the Fourth International Congress on HemofiltrationThe time has come for the formal development of a
held in Darmstadt, Germany on May 14th and 15th,specialty area called “Critical Care Nephrology.” The
1999. The aim of this issue is to provide the scientificfoundation for such an integrated approach has been
community with some of the latest contributions in thehemofiltration therapy. Although originally developed
field of hemofiltration and multiple organ failure, provid-to treat patients with end-stage renal disease, hemofil-
ing a balanced mix between established knowledge and
the newer results from clinical trials and basic research.
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failure, multiple organ failure.
tists and clinicians who are actively involved in the treat-
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consultation and informative reading not only for ex- sel (Bad Soden, Germany), Janssen-Cilag (Neuss, Ger-
perts, but also for the beginners of this field. many), Ray-Med (Wiesbaden, Germany), and A. Schulz
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